临床药师参与1例头孢曲松致小儿假性胆囊结石治疗分析  

One Case of Ceftriaxone-Induced Pseudo-Cholecystolithiasis Participated by Clinical Pharmacists

作　　者：郑滑 付海尔[1] 李瑜[1] 李小娜[1] 严瑛[1] Zheng Hua;Fu Haier;Li Yu;Li Xiaona;Yan Ying(Yellow River Water Resources Commission Yellow River Central Hospital, Henan Zhengzhou 450003, China)

机构地区：[1]黄河水利委员会黄河中心医院,河南郑州450003

出　　处：《儿科药学杂志》2019年第1期39-41,共3页Journal of Pediatric Pharmacy

摘　　要：目的:提高临床对头孢曲松所致小儿假性胆囊结石的认识。方法:临床药师通过参与1例患儿使用头孢曲松后出现假性胆囊结石的病例分析,探讨其形成机制及影响因素,并给出药学监护建议。结果:临床药师协助判断并给予建议处理后患儿症状缓解并好转出院。结论:临床医师应重视头孢曲松所致小儿假性胆囊结石的不良反应,临床药师应努力做好用药监护,最大限度保障患儿的用药安全。Objective:To improve the clinical understanding of ceftriaxone-induced pseudo-cholecystolithiasis in children.Methods: Clinical pharmacists discussed the formation mechanism and influencing factors of ceftriaxone-induced pseudo-cholecystolithiasis after participating into the case analysis of one child who developed pseudo-cholecystolithiasis after using ceftriaxone,and then provided pharmaceutical care suggestions.Results:The clinical pharmacists assisted the clinicians to judge and give suggestions for the patient, after the symptoms were relieved and improved,the child discharged from hospital.Conclusion:Clinical attention should be paid to the adverse drug reactions of children with ceftriaxone-induced pseudo-cholecystolithiasis.Moreover,clinical pharmacists are supposed to spare their efforts to provide pharmaceutical care to ensure the medication safety of the children.

关 键 词：临床药师 头孢曲松 假性胆囊结石 

分 类 号：R969.3[医药卫生—药理学]